We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Not so public health

23 July 2018 By Robert Cyran

A healthcare outfit owned by the private-equity firm is buying rival LifePoint for $2.7 bln, the latest deal in the sector. The two industries make good bedfellows. Buyout shops are cash-rich and hospitals can more easily slash expenses and raise prices if not publicly traded.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)